Thomas Kirchner

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Medicine, Oncology, Pharmacology +9

Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis

W Scheppach, H Sommer, Thomas Kirchner et al. · Gastroenterology · 1992 · 752 citations

Nursing, Immunology, Nutritional Sciences +16

Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus

Irith Baumann, Wasilis Kolowos, Reinhard Voll et al. · Arthritis & Rheumatism · 2002 · 557 citations

Medicine, Immunology, Pathology +17

Sarcoma classification by DNA methylation profiling

Christian Koelsche, Daniel Schrimpf, Damian Stichel et al. · Nature Communications · 2021 · 547 citations · Full text

Medicine, Cancer Biology, Oncology +17

Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas

Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp et al. · Modern Pathology · 2016 · 350 citations · Full text

Medicine, Cell Biology, Oncology +10